How much weight do you need to lose to feel less pain?
The amount of weight loss is directly tied to how much your pain improves. A network meta-analysis of 30 studies including over 4,600 people found that for every 1% of body weight you lose, your pain, stiffness, and function scores on the WOMAC scale improve by about 2% [5]. That means a 10% weight loss could yield roughly a 20% reduction in pain. The same analysis concluded that to get a 50% reduction in pain, you need to lose about 25% of your starting body weight [5] — a very large amount, typically only achieved with bariatric surgery or intensive medical programs.
The most powerful evidence comes from a 2024 randomized trial of semaglutide (a GLP-1 drug) in 407 people with obesity and knee osteoarthritis. Those who lost an average of 13.7% of their body weight reported a 42-point drop in pain (on a 0-100 scale), while those losing only 3.2% with placebo and diet advice had a 28-point drop [1]. The difference — about 14 more points of pain relief — was highly significant and shows that bigger weight loss brings bigger pain relief.
Which weight loss method works best for knee pain?
The most effective approach for pain relief is bariatric surgery, followed by intensive medical weight loss programs. The network meta-analysis ranked bariatric surgery as the most effective intervention for reducing knee pain, with a 63-point reduction on the WOMAC pain scale, compared to a 34-point reduction from a low-calorie diet plus exercise [5]. However, surgery is typically reserved for people with a BMI over 40, and a cost-effectiveness analysis found that gastric bypass surgery provides good value for money in this group, adding 1.35 quality-adjusted life-years at a cost of about $5,300 per QALY [7].
For people who don't want or qualify for surgery, GLP-1 drugs like semaglutide (Wegovy/Ozempic) are a powerful option. In the 2024 trial, semaglutide produced an average 13.7% weight loss and a 42-point pain reduction over 68 weeks [1]. Another study from the Shanghai Osteoarthritis Cohort found that people with knee osteoarthritis and type 2 diabetes who took GLP-1 drugs lost about 7.3 kg more weight than those not on the drugs, and had a significantly lower rate of knee surgery (1.7% vs 5.9%) [2]. Importantly, that study showed that the benefit was mediated by weight loss, not by blood sugar control [2].
Diet and exercise programs also work well, especially when delivered together. A 2021 trial of 415 people compared a telehealth exercise program alone versus exercise plus a very-low-calorie diet. At 6 months, the diet-plus-exercise group lost more weight and reported 1.5 points less pain (on a 0-10 scale) than the control group, while the exercise-only group reported 0.8 points less pain [4]. The diet-plus-exercise group also had significantly better function [4]. A cost-effectiveness analysis of this same program found that adding the dietary component was cost-effective, with an 86% probability of being worth the extra cost [3].
Are there any catches or limits to this evidence?
Yes, there are important caveats. First, not all weight loss methods for knee pain work equally well. A 2021 trial of liraglutide (another GLP-1 drug) found that while it caused significant weight loss (about 2.8 kg more than placebo over 52 weeks), it did NOT reduce knee pain any more than placebo [6]. The authors noted that participants had already lost at least 5% of their body weight before starting the drug, which may have limited the additional pain benefit [6]. This suggests that the relationship between weight loss and pain relief may not be linear — you may need to reach a certain threshold of weight loss before pain improves.
Second, weight loss seems to matter more for knee osteoarthritis than for hand osteoarthritis. A study from the Osteoarthritis Initiative found no association between weight change and hand pain or structural damage over 8 years [8]. So the benefits of weight loss appear specific to weight-bearing joints like the knees.
Third, the side effects of weight loss medications can be significant. In the semaglutide trial, 6.7% of participants stopped the drug due to side effects, mostly gastrointestinal issues like nausea and vomiting [1]. And while bariatric surgery is effective, it carries surgical risks and requires lifelong nutritional monitoring. Finally, the evidence strongly supports combining weight loss with exercise — the meta-analysis emphasized that exercise is essential to preserve lean muscle mass and avoid sarcopenia [5].
About These Sources
This answer is built on 8 peer-reviewed studies — published from 2021 to 2024, 1 from 2024 or later, 7 in Q1 journals, collectively cited 544 times — selected as the most relevant from 9 studies that passed quality screening, drawn from 65 papers retrieved from a database of over 500 million.
Sources used in this answer
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
In a 68-week randomized trial of 407 people with obesity and knee osteoarthritis, semaglutide led to 13.7% weight loss and a 42-point reduction in pain (WOMAC 0-100), significantly better than the 3.2% weight loss and 28-point reduction with placebo [1].
Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
In a prospective cohort study of over 1,800 people with knee osteoarthritis and type 2 diabetes, GLP-1 drug use was associated with 7.3 kg more weight loss, lower rates of knee surgery (1.7% vs 5.9%), and slower cartilage loss, with the benefit mediated by weight loss [2].
Cost‐Effectiveness of Telehealth‐Delivered Exercise and Dietary Weight Loss Programs for Knee Osteoarthritis Within a Twelve‐Month Randomized Trial
A cost-effectiveness analysis of a 12-month telehealth trial found that adding a dietary weight loss program to exercise was cost-effective for knee osteoarthritis, with an 86% probability of being worth the extra cost at $21,100 per QALY [3].
Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis
In a 12-month trial of 415 people with knee osteoarthritis and overweight/obesity, telehealth-delivered exercise plus a very-low-calorie diet reduced pain by 1.5 points (0-10 scale) more than control, and the diet-plus-exercise group did better than exercise alone [5].
Comparative efficacy of different weight loss treatments on knee osteoarthritis: A network meta‐analysis
A network meta-analysis of 30 studies (4,651 adults) found that bariatric surgery was the most effective weight loss intervention for knee pain (63-point WOMAC reduction), and that every 1% weight loss yields about 2% improvement in pain, function, and stiffness [6].
Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial.
In a 52-week trial of 156 people with knee osteoarthritis and overweight/obesity, liraglutide caused 2.8 kg more weight loss than placebo but did not reduce knee pain any more than placebo [7].
Cost‐Effectiveness of Surgical Weight‐Loss Interventions for Patients With Knee Osteoarthritis and Class III Obesity
A cost-effectiveness modeling study found that gastric bypass surgery for people with knee osteoarthritis and BMI ≥40 adds 1.35 quality-adjusted life-years at a cost of $5,300 per QALY, making it good value [8].
Association of Weight Loss and Weight Gain With Structural Defects and Pain in Hand Osteoarthritis: Data From the Osteoarthritis Initiative
In an analysis of 4,598 participants from the Osteoarthritis Initiative, weight change over 4-8 years was not associated with the development or progression of hand osteoarthritis or hand pain [9].